Phase 3 Readout~month

Phase 3 Topline: A Randomized, Double-masked, Parallel-group, Multicenter Clinical Study to Evaluate the Efficacy and

Drug
eylea
Indication
Diabetic Macular Edema

Other upcoming events for ALVO

Phase 1 StartPhase 1 Start: A Multicenter, Randomized, Double-Blind, 2-Treatment Arm Study to Assess Comparative Pharmacokinetic

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Randomized, Double-masked, Parallel-group, Multicenter Clinical Study to Evaluate the Efficacy and — ALVO Phase 3 Readout | BioSniper